Synopsis
This session explores advanced non-invasive tools for detecting and monitoring liver disease, focusing on how to select and interpret tests based on patient risk profiles and how to embed NIT-guided screening and follow-up into routine clinical pathways and workflows.
Agenda
Chairperson: Eugene Yu Jun Wong
|
0715-0725 |
An introduction to Non-Invasive Biomarkers in APAC |
|
0725-0740 |
From Biopsy to Biomarkers – and Beyond: The Past, Present & Future of Non-Invasive Quantitative Imaging Biomarkers Pierce Chow |
|
0740-0755 |
Bridging the Gap: Implementing NIT-Guided Care in Everyday Clinical Practice Learning Objectives Yock Young Dan |
|
0755-0800 |
Panel questions and discussion |
